目錄:MedChemExpress LLC>>信號通路>> Anastrozole | 阿那曲唑 | MedChemExpress (MCE)
CAS | 120511-73-1 | 純度 | 99.99% |
---|---|---|---|
分子量 | 293.37 | 分子式 | C??H??N? |
供貨周期 | 現貨 | 規格 | 10 mM * 1 mL |
貨號 | HY-14274 | 應用領域 | 醫療衛生,化工,生物產業,制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
CAS No. : 120511-73-1
MCE 國際站:Anastrozole
產品活性:Anastrozole 是一種選擇性的芳香酶 (aromatase) 抑制劑,抑制胎盤芳香化酶,IC50 為 15 nM。
研究領域:Metabolic Enzyme/Protease
作用靶點:Cytochrome P450
In Vitro: Anastrozole is a comparatively simple, achiral benzyltriazole derivative, that inhibits human placental aromatase with an IC50 of 15 nM. In the same assay it is 200 times as potent as aminoglutethimide (AG), twice as potent as 4-OHA and one third as potent as Fadrozole.
In Vivo: Groups of eight immature (22-day-old) female rats are given androstenedione (AD) (30 mg/kg) in arachis oil s.c. daily for3 days with or without various doses of Anastrozole p.o. on day 4 the uteri are dissected, blotted and weighed. An oral dose of 0.1 mg/kg of Anastrozole given on day 2 or day 3 of the cycle completely blocked ovulation. At the same daily dosage (0.1 mg/kg), Anastrozole completely extinguished the uterotrophic activity of exogenous AD in immature rats. In male pigtailed monkeys, twice-daily oral treatment with 0.1 mg/kg and above of Anastrozole reduced circulating oestradiol concentrations by 50-60%.
相關產品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Metabolism/Protease Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Antioxidant Compound Library | Oxygen Sensing Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Targeted Therapy Drug Library | Mitochondria-Targeted Compound Library | Rare Diseases Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Off-patent Drug Library | Highly Selective Inhibitors Library | Verapamil | Apigenin | Fenofibrate | Chlorpromazine hydrochloride | Ketoconazole | 1-Aminobenzotriazole | Letrozole | Abiraterone | Itraconazole | Cepharanthine | Quinidine (15% dihydroquinidine) | Diosmetin | Clarithromycin | Naringin | Gemfibrozil 1-O-β-glucuronide | Atovaquone | Fomepizole | Talarozole | Cobicistat | Salvianolic acid C | Hypericin | Methoxsalen | Sulfaphenazole | (S)-Mephenytoin | Furafylline | Gemfibrozil | HET0016
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds